Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study

Access to innovative drugs for metastatic lung cancer treatment in a French nationwide cohort: the TERRITOIRE study

Abstract Background Territorial differences in the access to innovative anticancer drugs have been reported from many countries. The objectives of this study were to evaluate access to innovative treatments for metastatic lung cancer in France, and to assess whether socioeconomic indicators were pre...

Full description

Bibliographic Details
Main Authors: Arnaud Scherpereel, Isabelle Durand-Zaleski, François-Emery Cotté, Jérôme Fernandes, Didier Debieuvre, Cécile Blein, Anne-Françoise Gaudin, Charlène Tournier, Alexandre Vainchtock, Pierre Chauvin, Pierre-Jean Souquet, Virginie Westeel, Christos Chouaïd
Format: Article
Language:English
Published: BMC 2018-10-01
Series:BMC Cancer
Subjects:
Metastatic lung cancer
Innovative treatments
France
Social deprivation
Online Access:http://link.springer.com/article/10.1186/s12885-018-4958-5

Internet

http://link.springer.com/article/10.1186/s12885-018-4958-5

Similar Items